Patent · US Active

Treating infections with ceftolozane/tazobactam in subjects having impaired renal function

US10933053B2 · kind B2 · utility

0Cited by

193References

34Claims

0Family size

Assignee

Merck Sharp & Dohme LLC · US

Inventors

Gopal Krishna · Dover, US
Gurudatt Chandorkar · Waltham, US
Elham Hershberger · Lexington, US
Benjamin L. Miller · Penfield, US
Alan Xiao · Zhuolan Township, TW

Key dates

Filing date	Jul 29, 2019
Grant date	Mar 2, 2021
Priority date	—
Expiry date	Jul 29, 2039

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY02A50/30
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Disclosed are methods of administering cephalosporin/tazobactam to human patients with end stage renal disease undergoing hemodialysis and suffering from a complicated intra-abdominal infection or a complicated urinary tract infection.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.